Earnings History Data for NGM Biopharmaceuticals (NGM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NGM Biopharmaceuticals

NGM Biopharmaceuticals Inc. is focused on developing novel therapeutics for underlying cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's product pipeline consists of NGM282, NGM313, NGM120, NGM217, NGM621, NGM386 and NGM395 which are in clinical stage. NGM Biopharmaceuticals Inc. is based in San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
04-11-2021 AH 4:05 PM ET
(Nov 4)
NGM NGM Biopharmaceuticals 1,480 -0.37 -0.38 0.00 NGM Biopharmaceuticals EPS beats by $0.01, misses on revenue
[11/4/2021 5:10 PM]
21.53 1.42 
(7.06%)
20.11 0.0 
(0.00%)
14.90 - 32.12 483,056 230,000 2,277
05-08-2021 AH 4:05 PM ET
(Aug 5)
NGM Ngm Biopharmaceuticals, Inc. 1,552 -0.48 -0.39 0.00 NGM Biopharmaceuticals EPS misses by $0.10, misses on revenue
[8/5/2021 5:18 PM]
25.44 2.40 
(10.42%)
22.39 -0.65 
(-2.82%)
14.90 - 32.12 494,722 420,000 410
06-05-2021 AH 4:05 PM ET
(May 6)
NGM Ngm Biopharmaceuticals, Inc. 2,090 -0.36 -0.42 0.00 NGM Biopharmaceuticals EPS beats by $0.05, misses on revenue
[5/6/2021 5:09 PM]
26.77 0.02 
(0.07%)
26.77 0.0 
(0.00%)
14.93 - 32.12 70,745 120,000 1,301